Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165% Potential Gain.

LIVE QUOTE Original Report: Initiating Coverage...
Revive Therapeutics

Revive Therapeutics (RVVTF, RVV): Updates and News Archive.

Recent Headlines (See FDA Filing Submission at Bottom) LIVE QUOTE

Track Record

Click to open 21 clients up over $100 million, 13 clients up over ten-fold in value.
CPRE Networks

Adding VYRE Network (CAPV) to the Watch List.

Look What We Found. Our First Internet Play in Ages, And It's a Doozy. We would categorize this...

OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.

Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share. Without disrupting legacy sales - CEO Shai...
Ehave, Psychedelic Stock Review

Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company

WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE What exactly is a favorite? First...

Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety and Efficacy Review.

Investment Banker Buy Rating Maintained: DSMB Gives the Thumbs Up – Data in Early 2022. CITIUS NEWS ARCHIVE
Hea;thLynked, Biotech Stock Review

Up 191%, HealthLynked (HLYK) Reporting Decent Numbers.

Up as much as 417% from where we added it to the Watch List, the Company continues to report increasing revenues while...

Bitcoin $30,000. Time to Bargain Hunt? Read This First.

The Bit Short: Inside Crypto’s Doomsday Machine Scary article on Tether/Bitcoin posted on...
Internet Stock Review, Draganfly

Meet Draganfly (DFLYF) the Tesla of Drones.

A New Leader In The Drone Industry Emerges US Government Bans Chinese Drones Surprise...

Latest article

Iconic Brands (ICNB) Reports Revenues of $13.8 Million vs $4 Million. Bounces 40% Intraday.

After a Rough Six Months in the market, Nine Month Numbers Propels the Stock 40% Higher Signaling Possible Bottoming Process. ...

Adding Silo Pharma (SILO) $3.50 to Watch List.

Look What We Found! We launched the Psychedelic Stock Review a little more than a year ago and decided...

Alzheimer Drug Trials

A winner is crowned in head-to-head Alzheimer's battle between Biogen's Aduhelm and Lilly - Dec 1, 2022 Eli...